What's that meanI'm only guessing, but would it be fair to say 3rd party discussions, otherwise if its just mates around the boardroom table why bother telling us !
In parallel, we are advancing commercialisation discussions and look forward to providing more updates on the registration of EMD-RX5 in future announcements.”
Who knows, guess we will find out at some point !
Ann: Emyria expands clinical sites for EMD-RX5 Phase 3 trial, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
0.001(2.44%) |
Mkt cap ! $25.68M | |||
| Open | High | Low | Value | Volume |
| 4.1¢ | 4.2¢ | 4.1¢ | $65.43K | 1.567M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1025000 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 105384 | 1 |
View Market Depth
| Last trade - 10.48am 30/07/2025 (20 minute delay) ? |
| EMD (ASX) Chart |